(2E,6Z)-Nona-2,6-dienenitrile
Common Name: |
(2E,6Z)-Nona-2,6-dienenitrile |
IUPAC Name: |
(2E,6Z)-nona-2,6-dienenitrile |
Molecular Formula: |
C9H13N |
SMILES: |
CCC=CCCC=CC#N |
Inchi: |
1S/C9H13N/c1-2-3-4-5-6-7-8-9-10/h3-4,7-8H,2,5-6H2,1H3/b4-3-,8-7+ |
Inchi Key: |
DSOXXQLCMAEPEZ-ODYTWBPASA-N |
Cas No: |
97752-28-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
135.21 |
Mass (g/mol) |
135.105 |
Molar Refractivity |
44.18 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
|
TPSA |
23.79 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
231.00 to 232.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.062 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.44 |
LogP |
2.813 |
iLOGP |
2.51 |
XLOGP3 |
2.47 |
WLOGP |
2.81 |
MLOGP |
2.19 |
ESOL Log S |
-1.97 |
ESOL Solubility (mg/ml) |
1.45 |
ESOL Solubility (mol/l) |
0.011 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.61 |
Ali Solubility (mg/ml) |
0.33 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.72 |
Silicos-IT Solubility (mg/ml) |
2.61 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.37 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.333 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.653 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |